Tilray | TRLY - Capital Y Las Reservas





Capital Y Las Reservas Cambio Fecha
Acasti Pharma USD 64.89M 2.07M 2025-12
Akebia Therapeutics USD 25.02M 2.36M 2026-06
Alaunos Therapeutics USD 1.29M 865K 2026-03
Aurora Cannabis CAD 511.83M 24.53M 2026-03
Avita Medical AUD -16.65M 3.76M 2025-12
Canopy Growth CAD 697.59M 60.58M 2026-03
Cronos Group USD 1.07B 4.99M 2026-06
Dianthus Therapeutics USD 1.17B 29.29M 2026-06
Divis Laboratories Ltd INR 167.61B 13.48B 2026-03
Ionis Pharmaceuticals USD 439.74M 51.68M 2026-06
IQVIA Holdings USD 6.17B 50M 2026-06
Knight Therapeutics CAD 767.27M 480K 2025-12
Moderna USD 6.76B 647M 2026-06
Organigram Holdings CAD 371.81M 2.36M 2026-03
Organon & Co USD 1.01B 103M 2026-06
Revvity USD 7.18B 67.62M 2026-03
Tectonic Therapeutic USD 230.42M 20.91M 2026-03
Tilray USD 1.58B 39.08M 2025-09
Viatris USD 14.26B 397.3M 2026-06
Xeris Pharmaceuticals USD -9.73M 22.74M 2026-06
Zealand Pharma A/S 14.47B 361.61M 2026-03